Calendar Abivax

Equities

Market Closed - Euronext Paris Other stock markets 11:35:16 2023-12-01 am EST			5-day change	1st Jan Change
9.450 ^EUR	+3.17%		-1.36%	+52.91%

Oct. 25	Abivax Raises $235.8 Million via Nasdaq IPO	MT
Oct. 24	Abivax Closes Nasdaq IPO With $235.8 Million in Gross Proceeds	MT

2314ba8836.6f1AaZlStMc0SKCDtRNJMlPNO3iUYmdLhky6A8NNcK4.3M5zDs5q2epYLPHM4SYYdDuETkykEQgp2Q_idpYeI5qsqQ8-yj_rglcxkA~e00ef23f3ef2d92915a0d2fcc750f394

2024-01-24	Crohn’s & Colitis Congress
2024-02-21	ECCO
2024-03-13	Q4 2023 Earnings Release (Projected)
2024-09-26	Q2 2024 Earnings Release (Projected)
2025-03-12	Q4 2024 Earnings Release (Projected)
2025-09-25	Q2 2025 Earnings Release (Projected)

2023-11-29 03:30 pm	Piper Sandler Healthcare Conference
2023-10-19	ACG Meeting
2023-10-16 05:30 am	United European Gastroenterology Meeting - OP077
2023-10-15 09:30 am	United European Gastroenterology Week - Abstract Number : MP085
2023-10-15 04:00 am	United European Gastroenterology Week - Abstract Number : PP0892
2023-09-21 12:00 pm	Q2 2023 Earnings Release
2023-06-05 04:00 am	Annual General Meeting
2023-04-19 03:00 pm	Q4 2022 Earnings Release
2023-03-03 06:30 am	ECCO Congress - Poster No - P001
2023-01-08	JP Morgan Healthcare Conference
2023-01-08	LifeSci Partners Corporate Access Conference
2022-11-09 03:00 am	Extraordinary Shareholders Meeting
2022-09-15 12:00 pm	Interim 2022 Earnings Release
2022-06-09 04:00 am	Annual General Meeting
2022-06-01 02:40 pm	EULAR Congress
2022-03-16 01:00 pm	FY 2021 Earnings Release
2022-02-17 06:00 am	ECCO Abivax Satellite Symposium
2022-01-19	American Society of Clinical Oncology Gastrointestinal Cancers Symposium
2022-01-13 12:00 pm	JP Morgan Healthcare Conference
2021-10-04 07:00 am	UEG Week Virtual Symposium

Fiscal Period	December	2018	2019	2020	2021	2022	2023
Net sales Million EUR	Released Forecast Spread	0,80 0,60 33.33%	0,00 0,00 -	1,70 7,07 -75.94%	9,70 33,7 -71.2%	0,10 1,65 -93.94%	2,34
EBITDA Million EUR	Released Forecast Spread	-19,0 -18,7 -1.76%	-33,2 -31,4 -5.78%	-37,9 -32,3 -17.47%	-42,4 -47,3 10.35%	-56,6 -55,2 -2.49%	-101
EBIT Million EUR	Released Forecast Spread	-19,1 -17,7 -7.71%	-33,3 -23,8 -39.92%	-38,0 -35,8 -6.24%	-42,6 -47,7 10.63%	-56,6 -55,5 -1.98%	-102
Earnings before Tax (EBT) Million EUR	Released Forecast Spread	-19,8 -17,6 -12.18%	-34,9 -33,0 -5.76%	-40,1 -33,4 -20.17%	-45,6 -51,5 11.4%	-74,3 189 -139.32%	-121
Net income Million EUR	Released Forecast Spread	-15,8 -16,6 4.63%	-30,6 -19,0 -61.48%	-37,6 -34,4 -9.26%	-41,4 -20,8 -99.18%	-69,8 -63,6 -9.83%	-107
EPS EUR	Released Forecast Spread	-1,34 -1,74 22.49%	-2,51 -2,03 -23.54%	-2,62 -2,63 0.34%	-2,47 -2,87 13.84%	-3,13 -0,87 -259.77%	-1,91
Announcement Date		14/03/19	16/03/20	31/03/21	16/03/22	19/04/23	-

Fiscal Period	December	2022 S1	2023 S1	2023 S2	2024 S1	2024 S2
Net sales Million EUR	Released Forecast Spread			2,30	2,30	2,30
EBIT Million EUR	Released Forecast Spread	-18,6
Net income Million EUR	Released Forecast Spread	-29,6	-52,0	-45,0	-55,9	-74,8
EPS EUR	Released Forecast Spread		-1,45	-0,85	-0,89	-1,19
Announcement Date		09/15/22	09/29/23	-	-	-

2024-01-22	Q3 2024 Earnings Release (Projected)
2024-01-23	Q4 2023 Earnings Release (Projected)
2024-01-31	Q3 2023 Earnings Release (Projected)
2024-02-02 12:45 am	Q4 2023 Earnings Release
2024-02-05	Q1 2024 Earnings Release (Projected)
2024-02-05	Q2 2024 Earnings Release (Projected)
2024-02-05	Q4 2023 Earnings Release (Projected)
2024-02-06	Q1 2024 Earnings Release (Projected)
2024-02-07	Q4 2023 Earnings Release (Projected)
2024-02-07	Q4 2023 Earnings Release (Projected)

2023-11-28 04:15 pm	Q3 2023 Earnings Release
2023-11-15	Q3 2023 Earnings Release (Projected)
2023-11-15 04:01 pm	Q3 2023 Earnings Release
2023-11-14 04:05 pm	Q3 2023 Earnings Release
2023-11-14 04:01 pm	Q3 2023 Earnings Release
2023-11-14 07:00 am	Q3 2023 Earnings Release
2023-11-14 06:30 am	Q3 2023 Earnings Release
2023-11-13	Q3 2023 Earnings Release
2023-11-13 08:15 pm	Q3 2023 Earnings Release
2023-11-13 04:07 pm	Q4 2023 Earnings Release